Note 2 - Going Concern Uncertainty

3 Months Ended

Mar. 31, 2017

Notes

Note 2 - Going Concern Uncertainty

NOTE 2 – Going Concern Uncertainty

The consolidated financial statements have been prepared on a “going concern” basis, which contemplates the realization of assets and liquidation of liabilities in a normal course of business. As of March 31, 2017, the Company had cash and cash equivalents of $29,822 and negative working capital of $495,394. For the three months ended March 31, 2017 and 2016, the Company had net gain of $24,100 and net loss of $144,610, respectively. Absent to the gain from derivative liability, the net loss for the three months ended March 31, 2017 and 2016 would be $172,579 and $144,610, respectively. These factors raise substantial doubt as to the Company’s ability to continue as a going concern.  The Company plans to improve its financial condition by raising capital through sales of shares of its common stock.  Also, the Company plans to start a health supplements business to attain profitable operations. The consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.